263 related articles for article (PubMed ID: 36999977)
1. Ferritin in cancer therapy: A pleiotropic tumoraffin nanocage-based transport.
Deng G; Li Y; Liang N; Hu P; Zhang Y; Qiao L; Zhang Y; Xie J; Luo H; Wang F; Chen F; Liu F; Xu D; Zhang J
Cancer Med; 2023 May; 12(10):11570-11588. PubMed ID: 36999977
[TBL] [Abstract][Full Text] [Related]
2. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
3. Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy.
Wang Z; Zhao Y; Zhang S; Chen X; Sun G; Zhang B; Jiang B; Yang Y; Yan X; Fan K
Theranostics; 2022; 12(4):1800-1815. PubMed ID: 35198074
[No Abstract] [Full Text] [Related]
4. Bioengineered Ferritin Nanocarriers for Cancer Therapy.
Sun X; Hong Y; Gong Y; Zheng S; Xie D
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209892
[TBL] [Abstract][Full Text] [Related]
5. Targeted cancer cell delivery of arsenate as a reductively activated prodrug.
Cioloboc D; Kurtz DM
J Biol Inorg Chem; 2020 May; 25(3):441-449. PubMed ID: 32189144
[TBL] [Abstract][Full Text] [Related]
6. Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer.
Truffi M; Fiandra L; Sorrentino L; Monieri M; Corsi F; Mazzucchelli S
Pharmacol Res; 2016 May; 107():57-65. PubMed ID: 26968122
[TBL] [Abstract][Full Text] [Related]
7. Ultra-high loading of sinoporphyrin sodium in ferritin for single-wave motivated photothermal and photodynamic co-therapy.
Huang C; Chu C; Wang X; Lin H; Wang J; Zeng Y; Zhu W; Wang YJ; Liu G
Biomater Sci; 2017 Jul; 5(8):1512-1516. PubMed ID: 28617486
[TBL] [Abstract][Full Text] [Related]
8. Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting.
Khoshnejad M; Parhiz H; Shuvaev VV; Dmochowski IJ; Muzykantov VR
J Control Release; 2018 Jul; 282():13-24. PubMed ID: 29522833
[TBL] [Abstract][Full Text] [Related]
9. Co-Encapsulation of Hydrophilic and Hydrophobic Drugs into Human H Chain Ferritin Nanocarrier Enhances Antitumor Efficacy.
Ning C; Dong Y; Yang K; Li X; Wang F; Zhang Y
ACS Biomater Sci Eng; 2023 May; 9(5):2572-2583. PubMed ID: 37071410
[TBL] [Abstract][Full Text] [Related]
10. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
11. Combined concurrent photodynamic and gold nanoshell loaded macrophage-mediated photothermal therapies: an in vitro study on squamous cell head and neck carcinoma.
Trinidad AJ; Hong SJ; Peng Q; Madsen SJ; Hirschberg H
Lasers Surg Med; 2014 Apr; 46(4):310-8. PubMed ID: 24648368
[TBL] [Abstract][Full Text] [Related]
12. Simple plant-based production and purification of the assembled human ferritin heavy chain as a nanocarrier for tumor-targeted drug delivery and bioimaging in cancer therapy.
Knödler M; Opdensteinen P; Sankaranarayanan RA; Morgenroth A; Buhl EM; Mottaghy FM; Buyel JF
Biotechnol Bioeng; 2023 Apr; 120(4):1038-1054. PubMed ID: 36539373
[TBL] [Abstract][Full Text] [Related]
13. Effective Delivery of Paclitaxel-Loaded Ferritin via Inverso CendR Peptide for Enhanced Cancer Therapy.
Dong Y; Yang K; Xu Z; Li X; Wang F; Zhang Y
Mol Pharm; 2023 Feb; 20(2):942-952. PubMed ID: 36574345
[TBL] [Abstract][Full Text] [Related]
14. Ferritin drug carrier (FDC) for tumor targeting therapy.
He J; Fan K; Yan X
J Control Release; 2019 Oct; 311-312():288-300. PubMed ID: 31494184
[TBL] [Abstract][Full Text] [Related]
15. Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies.
Monti DM; Ferraro G; Merlino A
Nanomedicine; 2019 Aug; 20():101997. PubMed ID: 31028889
[TBL] [Abstract][Full Text] [Related]
16. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
[TBL] [Abstract][Full Text] [Related]
18. ERK-Peptide-Inhibitor-Modified Ferritin Enhanced the Therapeutic Effects of Paclitaxel in Cancer Cells and Spheroids.
Dong Y; Ma Y; Li X; Wang F; Zhang Y
Mol Pharm; 2021 Sep; 18(9):3365-3377. PubMed ID: 34370483
[TBL] [Abstract][Full Text] [Related]
19. Ferritin-based nanomedicine for disease treatment.
Zhu Y; Zhu Y; Cao T; Liu X; Liu X; Yan Y; Shi Y; Wang JC
Med Rev (2021); 2023 Feb; 3(1):49-74. PubMed ID: 37724111
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
